These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35322580)

  • 1. Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy.
    Zhang X; Trendowski MR; Wilkinson E; Shahbazi M; Dinh PC; Shuey MM; ; Feldman DR; Hamilton RJ; Vaughn DJ; Fung C; Kollmannsberger C; Huddart R; Martin NE; Sanchez VA; Frisina RD; Einhorn LH; Cox NJ; Travis LB; Dolan ME
    Cancer Med; 2022 Jul; 11(14):2801-2816. PubMed ID: 35322580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations Between Perceived Stress and Chemotherapy-Induced Peripheral Neuropathy and Otoxicity in Adult Cancer Survivors.
    Miaskowski C; Paul SM; Mastick J; Abrams G; Topp K; Smoot B; Kober KM; Chesney M; Mazor M; Mausisa G; Schumacher M; Conley YP; Sabes JH; Cheung S; Wallhagen M; Levine JD
    J Pain Symptom Manage; 2018 Jul; 56(1):88-97. PubMed ID: 29524582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors.
    Trendowski MR; Wheeler HE; El-Charif O; Feldman DR; Hamilton RJ; Vaughn DJ; Fung C; Kollmannsberger C; Einhorn LH; Travis LB; Dolan ME
    Clin Cancer Res; 2020 Dec; 26(24):6550-6558. PubMed ID: 32998964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of chemotherapy-induced neurotoxicities on adult cancer survivors' symptom burden and quality of life.
    Miaskowski C; Mastick J; Paul SM; Abrams G; Cheung S; Sabes JH; Kober KM; Schumacher M; Conley YP; Topp K; Smoot B; Mausisa G; Mazor M; Wallhagen M; Levine JD
    J Cancer Surviv; 2018 Apr; 12(2):234-245. PubMed ID: 29159795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy.
    Sanchez VA; Dinh PC; Rooker J; Monahan PO; Althouse SK; Fung C; Sesso HD; Einhorn LH; Dolan ME; Frisina RD; Travis LB
    J Cancer Surviv; 2023 Feb; 17(1):27-39. PubMed ID: 36637632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors.
    Hjelle LV; Bremnes RM; Gundersen POM; Sprauten M; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Oldenburg J; Haugnes HS
    Urol Oncol; 2016 Nov; 34(11):487.e13-487.e20. PubMed ID: 27523611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hearing loss and tinnitus in survivors with chemotherapy-induced neuropathy.
    Miaskowski C; Paul SM; Mastick J; Schumacher M; Conley YP; Smoot B; Abrams G; Kober KM; Cheung S; Henderson-Sabes J; Chesney M; Mazor M; Wallhagen M; Levine JD
    Eur J Oncol Nurs; 2018 Feb; 32():1-11. PubMed ID: 29353626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variants in
    Wheeler HE; Gamazon ER; Frisina RD; Perez-Cervantes C; El Charif O; Mapes B; Fossa SD; Feldman DR; Hamilton RJ; Vaughn DJ; Beard CJ; Fung C; Kollmannsberger C; Kim J; Mushiroda T; Kubo M; Ardeshir-Rouhani-Fard S; Einhorn LH; Cox NJ; Dolan ME; Travis LB
    Clin Cancer Res; 2017 Jul; 23(13):3325-3333. PubMed ID: 28039263
    [No Abstract]   [Full Text] [Related]  

  • 9. Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.
    Brydøy M; Oldenburg J; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Hauge ER; Dahl O; Fosså SD
    J Natl Cancer Inst; 2009 Dec; 101(24):1682-95. PubMed ID: 19940282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic risk factors for radiation-associated ototoxicity: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort.
    Trendowski MR; Baedke JL; Sapkota Y; Travis LB; Zhang X; El Charif O; Wheeler HE; Leisenring WM; Robison LL; Hudson MM; Morton LM; Oeffinger KC; Howell RM; Armstrong GT; Bhatia S; Dolan ME
    Cancer; 2021 Nov; 127(21):4091-4102. PubMed ID: 34286861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer.
    Frisina RD; Wheeler HE; Fossa SD; Kerns SL; Fung C; Sesso HD; Monahan PO; Feldman DR; Hamilton R; Vaughn DJ; Beard CJ; Budnick A; Johnson EM; Ardeshir-Rouhani-Fard S; Einhorn LH; Lipshultz SE; Dolan ME; Travis LB
    J Clin Oncol; 2016 Aug; 34(23):2712-20. PubMed ID: 27354478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further Investigation of the Role of
    Drögemöller BI; Brooks B; Critchley C; Monzon JG; Wright GEB; Liu G; Renouf DJ; Kollmannsberger CK; Bedard PL; Hayden MR; Gelmon KA; Carleton BC; Ross CJD
    Clin Cancer Res; 2018 Apr; 24(8):1866-1871. PubMed ID: 29358504
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and Genome-wide Analysis of Cisplatin-induced Tinnitus Implicates Novel Ototoxic Mechanisms.
    El Charif O; Mapes B; Trendowski MR; Wheeler HE; Wing C; Dinh PC; Frisina RD; Feldman DR; Hamilton RJ; Vaughn DJ; Fung C; Kollmannsberger C; Mushiroda T; Kubo M; Gamazon ER; Cox NJ; Huddart R; Ardeshir-Rouhani-Fard S; Monahan P; Fossa SD; Einhorn LH; Travis LB; Dolan ME
    Clin Cancer Res; 2019 Jul; 25(13):4104-4116. PubMed ID: 30952644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic risk factors of cisplatin induced ototoxicity in adult patients.
    Talach T; Rottenberg J; Gal B; Kostrica R; Jurajda M; Kocak I; Lakomy R; Vogazianos E
    Neoplasma; 2016; 63(2):263-8. PubMed ID: 26774148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Audiologic Analyses After Cisplatin-Based Chemotherapy.
    Sanchez VA; Dinh PC; Monahan PO; Althouse S; Rooker J; Sesso HD; Dolan ME; Weinzerl M; Feldman DR; Fung C; Einhorn LH; Frisina RD; Travis LB
    JAMA Oncol; 2024 Jul; 10(7):912-922. PubMed ID: 38842797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer.
    Drögemöller BI; Monzon JG; Bhavsar AP; Borrie AE; Brooks B; Wright GEB; Liu G; Renouf DJ; Kollmannsberger CK; Bedard PL; Aminkeng F; Amstutz U; Hildebrand CA; Gunaretnam EP; Critchley C; Chen Z; Brunham LR; Hayden MR; Ross CJD; Gelmon KA; Carleton BC
    JAMA Oncol; 2017 Nov; 3(11):1558-1562. PubMed ID: 28448657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer.
    Dolan ME; El Charif O; Wheeler HE; Gamazon ER; Ardeshir-Rouhani-Fard S; Monahan P; Feldman DR; Hamilton RJ; Vaughn DJ; Beard CJ; Fung C; Kim J; Fossa SD; Hertz DL; Mushiroda T; Kubo M; Einhorn LH; Cox NJ; Travis LB;
    Clin Cancer Res; 2017 Oct; 23(19):5757-5768. PubMed ID: 28611204
    [No Abstract]   [Full Text] [Related]  

  • 18. Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study.
    Haugnes HS; Stenklev NC; Brydøy M; Dahl O; Wilsgaard T; Laukli E; Fosså SD
    Acta Oncol; 2018 Aug; 57(8):1075-1083. PubMed ID: 29384420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments.
    Ardeshirrouhanifard S; Fossa SD; Huddart R; Monahan PO; Fung C; Song Y; Dolan ME; Feldman DR; Hamilton RJ; Vaughn D; Martin NE; Kollmannsberger C; Dinh P; Einhorn L; Frisina RD; Travis LB
    Ear Hear; 2022; 43(3):794-807. PubMed ID: 35067571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics.
    Travis LB; Fossa SD; Sesso HD; Frisina RD; Herrmann DN; Beard CJ; Feldman DR; Pagliaro LC; Miller RC; Vaughn DJ; Einhorn LH; Cox NJ; Dolan ME;
    J Natl Cancer Inst; 2014 Mar; 106(5):. PubMed ID: 24623533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.